Jay Cascio, Rph, Lbc Email and Phone Number
Jay Cascio, Rph, Lbc work email
- Valid
- Valid
Jay Cascio, Rph, Lbc personal email
- Valid
A driven and high-performing Senior Executive specializing in the Healthcare industry, with extensive experience in Account and Territory Market Access and Management, Business Development, Health Economic Modeling, Marketing Development, and Lean Six Sigma process improvement. Excels at facilitating a market presence while driving revenue growth within highly competitive markets, such as Oncology, Precision Medicine, Genetics, C-suite customer segment, large oncology & Urology practices and NAPBC-accredited breast centers and Commission on Cancer (COC) centers. Works to build, lead, and empower a truly dynamic sales arm to achieve key goals and continually expand a market presence. Proven success in driving peak organizational prosperity and profitability by continually evolving an already-dynamic sales enterprise.Sales Growth and Leadership:★ Grew and enhanced demand 300% in first year, resulting in 69% contribution of all incremental testing and 50% of total testing volume in prostate cancer division. ★ Exceeded all goals each year, contributing 50% of sales growth for entire Business Unit. ★ Built training and strategic selling strategy for COVID success, exceeding goal by 200%.★ Cultivated top 10% performance (ranked no. 3 of 25).★ Ranked no. 1 in oncology test revenue, no. 3 in OB-GYN test revenue, and no. 5 in imaging center revenue.Strategic Account Managment★ Targeted SAM accounts generated 43% of total volume and 130% of growth for urology business unit. ★★ Facilitated customer service and field sales alignment to decrease test cancellation from 10% to less than 5% - Industry Best. ★ Led Home Health pilot. Recognized for national impact within U.S. affiliate newsletter. ★ Served as field-based leader for Six Sigma project core team, resulting in $2.5 million incremental revenue.Awards★ Earned Urology Innovation Award ★ Led Six Sigma project, driving 20% increase in revenue for business unit. ★ Honored as inductee to President’s Council in back to back years. Ranked no. 2 and no. 1 (out of 126) in nation Cardiovascular, selling ReoPro (monoclonal antibody) ★ Territory ranked no. 1 dollar volume in US affiliate★ Won Rx for Success award in 1999 from Lilly USA Newsletter. ★ Earned wide array of awards, including for Coaching Award two years in a row, turning around district performance back to back years, and earning second-ranked district in 2005.
Eli Lilly And Company
View-
Senior Director Of External Engagement OncologyEli Lilly And Company May 2024 - PresentIndianapolis, Indiana, UsServe as the Senior Director of External Engagement for Oncology* Lead as the single point of contact for external engagement strategic coordination across the drug development pipeline (Pre-clinical to post launch) and across functions (Discovery, Development, Commercial, Med Affairs, VEO, etc.)Deliver Exceptional Customer Engagement and Experience: * Lead the development and oversight of individual Thought Leader engagement plans including preferences across all customer-facing roles and act as a guide to regions and affiliates.
-
Associate Director, Us Lilly Value And AccessEli Lilly And Company Jan 2023 - May 2024Indianapolis, Indiana, Us• Successfully led Prostate Cancer Launch planning for Lilly Value and Access; including market assessment, message development, training plan, tactic development, strategy & field execution for the field Oncology Account Management team. • Successfully collaborated cross functionally to develop and contribute at high level to cross-functional strategy and execution plan for: LVA, LPS, Medial, HCP targeting, GPO contracting and account success.• Lead LVA Prostate Market Segmentation work to include significant strategic intent for Urology and Veterans Administration Hospitals• Account segmentation – influenced data integration to support National Oncology Account target list; partnered with HCP team on target account integration.• Integrated prostate epidemiology work into Part D payer discussion plan; developed Information exchange strategy/execution plan• Finalized Prostate Integrated PRA Strategy (Commercial contracting, Payer Access, GRO account planning and execution)
-
Board Of Directors85 Patriot Fund Jan 2022 - Presenthttps://85patriotfund.org/our-story/ -
Vice President, Precision Oncology SalesSema4 Aug 2021 - Jan 2023Stamford, Connecticut, UsFacilitated cross-functional collaboration to achieve targeted business and contracting objectives for targeted customers. Drove incremental sales revenue and surfaced opportunities for broader partnerships, including clinical trial development/recruitment, informatics, and research. Expanded and grew laboratory sales revenue across company’s oncology somatic testing portfolio while supporting broader national oncology and business development teams across entire oncology testing portfolio in accordance with approved sales and marketing strategies. Served as key advocate for clinical value of oncology solutions and represented primary approach to provider service and patient care across all levels and call points in hospital, specialty clinic, and physician's office, including MDs, nurses, genetic counselors, and laboratory staff.Accomplishments★ Developed and implemented an effective sales strategy and concepts for the sales and hospital channel organizations. ★ Restructured sales team for Lean execution of corporate goals. ★ Established LEAD indicator dashboard for sales force capabilities. Iterated as required to ensure the business stayed focused on key organizational goals.★ Instituted real real-time analytics testing volume.★ Developed business plans that positioned Sema4 oncology portfolio to achieve revenue and business objectives by leading the development and growth of large accounts and assigned business partnerships ★ Exceeded plan with all-time-high testing volume within three months. 90% growth YoY. -
National Director Strategic AccountsMyriad Genetics Oct 2018 - May 2021Salt Lake City, Utah, UsSupervised and led seven direct reports performing strategic account manager responsibilities for C-suite customers in prostate cancer market (i.e., large urology group practices, IDN, and VA hospitals). Set goal and vision for strategic accounts. Formed collaborative partnerships with decision makers within accounts to conduct needs assessments and deliver compliant solutions that would increase access and the appropriate use of Myriad testing. Oversaw and facilitated key plan for managed markets. Developed HECON plan for MACRA (MIPS/APMs) and drove development for first urology alternative payment model (APM), MIPS quality projects, and regional payer sales alignment responsibility. Led and managed core efforts regarding marketing, training, strategic partnerships, and contracting, including physician associations (i.e., LUGPA, AUA, and AACU), GPOs (i.e., UroGPO, Cardinal, McKesson, and AmerisourceBergen), national pathology laboratory strategy and contracting (i.e., Quest/AmeriPath and Inform Dx Laboratories), new product development partnerships (pharma and technology), and C-suite selling resources (i.e., sales training, market access, and face-to-face execution). Accomplishments ★ 2016: Grew and enhanced demand 300% in first year, resulting in 69% contribution of all incremental testing and 50% of total testing volume in prostate cancer division. ★ 2017: Targeted SAM accounts generated 43% of total volume and 130% of growth for urology business unit (as non-SAM account declined testing). Exceeded all goals from 2018 to 2021, contributing 50% of sales growth for entire BU. ★ Earned Urology Innovation Award in 2018. ★ Led Six Sigma project, driving 20% increase in revenue for business unit. ★ Facilitated customer service and field sales alignment to decrease test cancellation from 10% to less than 5% (industry best). ★ Built training and strategic selling strategy for COVID success, exceeding goal by 200%. -
Associate Director Strategic AccountsMyriad Genetics Apr 2015 - Oct 2018Salt Lake City, Utah, UsLed and managed core efforts regarding marketing, training, strategic partnerships, and contracting, including physician associations (LUGPA, AUA, and AACU), GPOs (URO GPO, Cardinal, McKesson, and AmerisourceBergen), national pathology laboratory strategy and contracting (Quest/Ameripath and Inform Dx Laboratories), new product development partnerships (pharma and technology), and C-suite selling resources (i.e., sales training, market access, and face-to-face execution).
-
Strategic Account ManagerMyriad Genetics Nov 2012 - Apr 2015Salt Lake City, Utah, UsManaged C-suite customer segment, large oncology practices, and NAPBC-accredited breast centers and Commission on Cancer (COC) centers. Drove C-suite sell cycle management for clinical, operational, and financial goals, including quality assurance, pathway development, and adherence to metrics (i.e., downstream revenue projection). Utilized Lean and Six Sigma methodology to drive consistent, reliable, and dependable processes to support physician behavior and impact patient outcomes. Tapped for Regional market Access / Managed Care responsibility in 2013-2014 across North and South Carolina, Georgia, and Florida (Project S.H.I.E.L.D.). Oversaw and managed wide array of oncology accounts across territory, including Florida Cancer Specialists, Cleveland Clinic, 21st Century Oncology, Tennessee Oncology, Vanderbilt, The West Clinic, Georgia Cancer Specialists, Zangmeister Clinic, and South Carolina Oncology Associates. Directed and collaborated with regional account executives and area managers to target, plan, and drive test utilization within large oncology and cancer centers at clinical, financial, and operations level. Improved patient outcomes. Accomplishments ★ Ranked no. 1 in oncology test revenue, no. 3 in OB-GYN test revenue, and no. 5 in imaging center revenue.★ Cultivated top 10% performance (ranked no. 3 of 25).★ First Third Party Administrator contract for Project S.H.I.E.L.D.
-
National Sales DirectorFsc Pediatrics Apr 2011 - Nov 2012Directed and built all national sales initiatives for significant sales force expansion, including leadership competencies, sales competencies, compensation strategy and plan, overhaul of recruiting process, college internship program, strategies and policies for operational excellence, and successful launch of Besivance (partnership with Bausch + Lomb). Maintained significant roles in sales training, marketing, payer contracts, business development, sales operations, human resources, and regulatory compliance. Acted as member of executive team and actively participated in business development opportunities, including planning and executing June 2012 launch of Rapid POC diagnostic test (AdenoPlus).
-
Senior District Sales ManagerEli Lilly And Company Mar 2000 - Apr 2011Indianapolis, Indiana, UsOversaw customer segments in oncology, cardiology, primary care, pediatrics, obstetrics and gynecology, rheumatology, endocrinology, orthopedics, and pain management. Accomplishments ★ Earned wide array of awards, including for:✩ Coaching (2005 and 2004)✩ Turning around district performance (2004 and 2003), and earning second-ranked district in 2005 (for post-FORTEO launch in primary care). ★ Led 2005 home health pilot. ★ Recognized for national impact within U.S. affiliate newsletter. ★ Served as field-based leader for 2008 Six Sigma project core team, resulting in $2.5 million incremental revenue.
-
Human Resources/ RecruiterEli Lilly And Company Jan 2000 - Mar 2000Indianapolis, Indiana, UsDeveloped and implemented national recruiting strategy for cardiovascular hospital sales force expansion in 2000. Revamped and enhanced hospital recruiting strategy, and hired 18 sales representatives for expansion efforts.
-
Marketing Associate CardiologyEli Lilly And Company Dec 1998 - Jan 2000Indianapolis, Indiana, UsWorked to sell ReoPro (Abciximab, Specialty). Implemented medical and marketing strategy, including three national thought leader CME symposiums and thought leader roundtable forum, leading to position paper on Gp IIb and IIIa inhibitors and cardiac surgery in 2000 journal supplement publication, Annals of Thoracic Surgery. Drove development and implementation of U.S. health economic plan and strategy. Restructured ReoPro indigent patient program, with first-year savings of $250,000.
-
Cardiovascular SpecialistEli Lilly And Company Feb 1997 - Dec 1998Indianapolis, Indiana, Us★ President's Council 1997 & 1998 (Top 2% for sales and leadership)
-
Primary Care/ Sales RepresentativeEli Lilly And Company Aug 1994 - Feb 1997Indianapolis, Indiana, Us
-
Pharmacy ManagerJack Eckerd Corp. Jun 1993 - Jul 1994
-
Staff PharmacistJack Eckerd Corp. Aug 1990 - Jun 1993
Jay Cascio, Rph, Lbc Skills
Jay Cascio, Rph, Lbc Education Details
-
Northeastern UniversityPharmacy
Frequently Asked Questions about Jay Cascio, Rph, Lbc
What company does Jay Cascio, Rph, Lbc work for?
Jay Cascio, Rph, Lbc works for Eli Lilly And Company
What is Jay Cascio, Rph, Lbc's role at the current company?
Jay Cascio, Rph, Lbc's current role is Sr Executive | Market Access | Healthcare Business Development | Strategic Planning | Genomic & Genetic Testing | Oncology | Urology.
What is Jay Cascio, Rph, Lbc's email address?
Jay Cascio, Rph, Lbc's email address is ja****@****ma4.com
What schools did Jay Cascio, Rph, Lbc attend?
Jay Cascio, Rph, Lbc attended Northeastern University.
What skills is Jay Cascio, Rph, Lbc known for?
Jay Cascio, Rph, Lbc has skills like Pharmaceutical Sales, Pharmaceutical Industry, Oncology, Sales Force Development, Product Launch, Cardiology, Sales, Hospital Sales, Leadership, Sales Operations, Hospitals, Sales Management.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial